德谷胰島素

Clinical Trials

• PHASE3COMPLETED
  A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesNovo Nordisk A/S · NCT01849289
• PHASE4COMPLETED
  Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 DiabetesEmory University · NCT03336528
• PHASE3COMPLETED
  A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesNovo Nordisk A/S · NCT02034513
• PHASE3COMPLETED
  A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusNovo Nordisk A/S · NCT01835431
• COMPLETED
  A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical PracticeNovo Nordisk A/S · NCT05069545
• PHASE2COMPLETED
  A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DMGan and Lee Pharmaceuticals, USA · NCT06199505

via ClinicalTrials.gov

via Wikidata sitelinks · CC0